Source comparison
Travel with CJC-1295 Airplane TSA: Peptide vs Insulin Comparison
Legal Status Unscheduled research compound; no FDA approval for human use FDA-approved medication; Schedule RX Both allowed with documentation CJC-1295 requires research protocol letter; insulin only needs prescription label Temperature Tolerance Must remain 2
This comparison does not assign a generated winner or score.
- Legal Status
- Unscheduled research compound; no FDA approval for human use
- FDA-approved medication; Schedule RX
- Both allowed with documentation
- CJC-1295 requires research protocol letter; insulin only needs prescription label
- Temperature Tolerance
- Must remain 2–8°C; degrades above 25°C
- Can tolerate room temp (15–30°C) for 28 days once in use
- No active temperature monitoring by TSA
- CJC-1295 requires active cooling; insulin does not for short flights
- Reconstitution Status
- Lyophilized powder (stable) or reconstituted solution (fragile)
- Pre-filled pen or vial, pharmaceutical-grade stabilizers
- Lyophilized powder may trigger questions
- Reconstituted CJC-1295 is exponentially more fragile than any insulin product
- Documentation Needed
- Research protocol or institutional letter + vial label
- Prescription label sufficient
- Both require labeled vials
- CJC-1295 benefits from MSDS for international travel; insulin does not
- Screening Likelihood
- Moderate (unfamiliar compound to most agents)
- Low (agents recognize insulin products)
- Secondary screening possible for CJC-1295
- Lead with 'research peptide for metabolic studies' to reduce questioning